Popular Articles

Tulip Telecom Q1 net up 63% at Rs 75 cr
Enterprise communications services provider Tulip Telecom today said its consolidated net profit has increased by 63.25 per cent to Rs 75.04 crore for the first quarter ended June 30, 2009.

'Consolidation will happen in the domestic drug industry'
P B Jayakumar / Mumbai September 25, 2009, 0:10 IST

News of the day

Centre talking to states on ArcelorMittal, Posco projects
Union Steel Minister Virbhadra Singh today said the Centre is in talks with the Jharkhand and Orissa governments to facilitate the multi-billion dollar India projects of global steel giants ArcelorMittal and Posco.
Small Business

Natco to release 1 mn Natflu doses by Oct end

Hyderabad-based drug maker Natco Pharma Limited will be releasing into the market over 1 million doses (10 million tablets) of Natflu, its medicine for treatment of swine flu, by the end of next month. - Sanofi bags order from US for supplying swine flu vaccine - "H1N1 virus has not mutated, vaccines on track" - US body to work with Andhra govt - Works still incomplete on Dasara eve - Obama announces plan to expand fight against swine flu - H1N1 drug trial talks next week With H1N1 virus spreading in the country, "we will be required to supply at least 1 million doses of Natflu by the end of October," Natco director and chief financial officer, P Bhaskara Narayana, said adding that the cost of each dose was pegged at Rs 480. Natco has so far released into the market 125,000 doses of Natflu, which are currently available in 33 medical shops, including 25 MedPlus shops, in Hyderabad. “The drug will be now made available throughout the city within a week and in 500-600 medical shops across the country by October 15,” Narayana told mediapersons. He said Natco would also be launching paediatric doses (in syrup form) of Natflu in 45 days. At present, the company is supplying only 75 mg Natflu tablets, which is basically an adult dosage. Narayana explained that the price of a Natflu tablet was about Rs 3 higher than that of the competitor"s drug because of improved package in an air-tight container. The company"s package would enhance the shelf life of the drug by one year. Natco, however, is supplying Natflu to the government at Rs 275 a dose. Narayana said this was possible as the supplies meant for government does not include taxes and distributor’s margin. Natflu is being produced at the company"s US Food and Drug Administration approved facility near here. “It has adequate capacity and we can meet whatever is the demand for the drug,” Narayana said. Natco has tied up with an overseas company and also a domestic outfit for supply of raw material. Natco’s scrip on the Bombay Stock Exchange closed at Rs 139.25 on Tuesday, up 10.82 per cent over the previous trading day’s close of Rs 125.65.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):